Goto Kashia, Watanabe Daisuke, Takano Hiromitsu, Yanagida Kazuki, Kawae Norikazu, Kajihara Hajime, Mizushima Akio
Department of Palliative Medicine, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.
Department of Urology, Koto Hospital, Tokyo 136-0072, Japan.
Cancers (Basel). 2025 Jun 25;17(13):2131. doi: 10.3390/cancers17132131.
: Prognostic information for nonmetastatic prostate cancer (nmPC) patients with prevalent vertebral fractures (PVFs) is very limited. Vertebral fractures can impair physical function, limit activities of daily living, and decrease quality of life. Prevention of vertebral fractures may be important to improve patient prognosis. This study aims to investigate the impact of the presence and severity of PVFs on overall survival in patients with nmPC undergoing androgen deprivation therapy (ADT). : A total of 275 men (median age: 73 years) with nmPC who underwent ADT were studied retrospectively. The median observation period was 55 months. Variables included age, body mass index, T classification, N classification, Gleason score, and pretreatment serum prostate-specific antigen levels. PVF was diagnosed from the sagittal computed tomography images of Th1 to L5 before initiating ADT, and the severity was determined by the number of PVFs and the Semiquantitative (SQ) method. Hazard ratios and 95% confidence intervals for overall survival were calculated using the Cox proportional hazards model. : During the observation period, 30 patients died from all causes. Multivariate Cox regression analysis identified multiple PVFs and high-grade PVFs, as determined by the SQ method, as significant predictors of overall survival. The analysis utilized two adjustment models: one adjusted for age only and the other adjusted for age, Gleason score, and clinical T stage. : Multiple PVFs and high-grade PVF determined by the SQ method prior to ADT initiation were associated with higher all-cause mortality in nmPC patients treated with ADT.
对于患有既往椎体骨折(PVF)的非转移性前列腺癌(nmPC)患者,预后信息非常有限。椎体骨折会损害身体功能,限制日常生活活动,并降低生活质量。预防椎体骨折对于改善患者预后可能很重要。本研究旨在调查PVF的存在和严重程度对接受雄激素剥夺治疗(ADT)的nmPC患者总生存期的影响。
对总共275名接受ADT的nmPC男性患者(中位年龄:73岁)进行了回顾性研究。中位观察期为55个月。变量包括年龄、体重指数、T分期、N分期、Gleason评分和治疗前血清前列腺特异性抗原水平。在开始ADT之前,从Th1至L5的矢状位计算机断层扫描图像诊断PVF,并通过PVF的数量和半定量(SQ)方法确定其严重程度。使用Cox比例风险模型计算总生存期的风险比和95%置信区间。
在观察期内,30名患者死于各种原因。多变量Cox回归分析确定,通过SQ方法确定的多个PVF和高级别PVF是总生存期的重要预测因素。该分析使用了两种调整模型:一种仅根据年龄进行调整,另一种根据年龄、Gleason评分和临床T分期进行调整。
在开始ADT之前通过SQ方法确定的多个PVF和高级别PVF与接受ADT治疗的nmPC患者较高的全因死亡率相关。